Transforming nanomedicines from lab scale production to novel clinical modality
D Landesman-Milo, D Peer - Bioconjugate chemistry, 2016 - ACS Publications
The use of nanoparticles as anticancer drug carriers has been studied for over 50 years.
These nanoparticles that can carry drugs are now termed “nanomedicines”. Since the …
These nanoparticles that can carry drugs are now termed “nanomedicines”. Since the …
Improved drug delivery and therapeutic efficacy of PEgylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model
Targeted cancer therapy is a powerful therapeutic strategy to management of cancer. HER2
as an anticancer target has long been studied. Its overexpression plays an important role in …
as an anticancer target has long been studied. Its overexpression plays an important role in …
Peptide-based ligand for active delivery of liposomal doxorubicin
Doxorubicin (DOX) has been extensively used in the clinic to treat malignant tumors such as
leukemias and Hodgkin's lymphoma. However, the severe cardiotoxicity associated with the …
leukemias and Hodgkin's lymphoma. However, the severe cardiotoxicity associated with the …